New York State Certifies GenetWorx to Perform Drug-Response Panel | GenomeWeb

NEW YORK (GenomeWeb) – GenetWorx said today that it has been certified by New York State to perform its drug-response genetic testing service on samples collected in the state.

The certification means Glen Allen, Va.-based GenetWorx is able to provide the test to patients in all 50 states in the US, it said. The lab is also CLIA certified.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.